Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
32.28 CHF | +0.47% |
|
+0.19% | +19.29% |
06-14 | Sandoz AG Re-Submits the Biosimilar Drug EG12014 (Trastuzumab Biosimilar) 150 Mg Powder BLA to the US FDA | CI |
06-07 | AbbVie's tight grip on Humira market raises concerns about biosimilars | RE |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
SANDOZ GROUP AG | Generic Pharmaceuticals | +0.47% | +0.19% | +19.29% | - | - | 15.45B | ![]() | ![]() | ![]() |
Technical Rankings Surperformance
- Stock Market
- Equities
- SDZ Stock
- Charts Sandoz Group AG
- Comparison Chart